Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £3.95m
AST Live PriceLast checked at - London Stock Exchange

Intraday Ascent Resources Share Chart

Private Placement and Loan Conversion

Today 09:38

RNS Number : 2065J
Ascent Resources PLC
22 June 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY IN THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. PLEASE SEE THE SECTION ENTITLED "IMPORTANT INFORMATION" TOWARDS THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EU (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

22 June 2026

Ascent Resources plc

("Ascent" or the "Company")

Private Placement and Loan Conversion

Ascent Resources Plc (LON: AST), the onshore US focused oil and gas company, is pleased to announce that it has raised gross proceeds of £400,000 through a private placement of new ordinary shares in the Company (the "Placing").

Highlights

§ Gross proceeds of £400,000 raised at a price of 0.5 pence per new ordinary share;

§ 200% warrant cover - two (2) warrants attached to each Placing Share, exercisable at 0.5 pence per share for a period of four (4) years from Admission, incorporating a reset mechanism to protect warrant holders in the event of any future equity raise below 0.5 pence per share; and

§ Net proceeds of £387,500 (after placing commission) to be used to develop the Company's strategy and for general working capital purposes.

Placing Details

The Company has raised gross proceeds of £400,000 (before expenses) by way of a private placement of 80,000,000 new ordinary shares of 0.5 pence each in the capital of the Company (the "Placing Shares") at a price of 0.5 pence per Placing Share (the "Placing Price") to a number of new and existing investors (the "Placees").

The Placing Shares will rank pari passu in all respects with the existing ordinary shares in the capital of the Company and will be issued on a non-pre-emptive basis.

Warrants

Each Placing Share will have two (2) warrants attached (the "Warrants. Each Warrant will entitle the holder to subscribe for one (1) new ordinary share in the capital of the Company at an exercise price of 0.5 pence per share. The Warrants will be exercisable in cash at any time during the period of four (4) years from the date of Admission of the Placing Shares.

Reset Mechanism: The Warrants will include a price reset mechanism designed to protect warrant holders against future equity raises below the current Placing Price. Specifically, if the Company issues any new equity securities at a price per share below 0.5 pence during the term of the Warrants, the exercise price of the Warrants will automatically reset to such lower issue price. Full details of the reset provisions will be set out in the warrant instrument.

Loan Conversion

In addition, pursuant to a Conversion Notice dated 19 June 2026, the Company is converting US$150,000 of outstanding principal under its Investment Agreement with RiverFort Global Opportunities PCC Limited into equity. The Company will issue 22,727,270 new ordinary shares at 0.5 pence per share ("Conversion Shares") together with 11,363,635 Preference 2 Shares (one half Preference 2 Share per ordinary share, pursuant to the June 2024 deed of consent and amendment).

This conversion cures and discharges in full the reprofiled balance of the repayment originally due on 21 April 2026 (as extended to 6 June 2026 under the May 2026 Deed of Amendment and Restatement).

Post conversion, the balance on the Riverfort CLN is $1,004,469.43.

The new ordinary shares will rank pari passu with the existing ordinary shares and the Placing Shares and will be issued on a non-pre-emptive basis.

Use of Proceeds

The net proceeds from the Placing will be used to develop the Company's strategy and for general working capital purposes. This will support the advancement of Ascent's strategic initiatives, ongoing operations, and provide flexibility to pursue value-accretive opportunities in line with the Board's current focus on onshore gas assets and other corporate objectives.

Admission to Trading on AIM

Application will be made to the London Stock Exchange for the admission of the Placing Shares and Conversion Shares to trading on AIM ("Admission"). It is expected that Admission will become effective at 8.00 a.m. on or around 26 June 2026.

Total Voting Rights

In accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following Admission, the Company will have 934,937,857 Ordinary Shares in issue, none of which will be held in treasury. Accordingly, the total number of voting rights in the Company will be 934,937,857 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Ascent Resources plc

Jean-Michel Doublet

info3@ascentresources.co.uk

 

Zeus, Nominated Adviser & Broker

James Joyce / James Bavister

0203 829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGZVRZFGVZG
Date   Source Headline
9th Dec 20247:00 amRNSNew Joint Venture & Board Changes
29th Oct 20243:53 pmRNSHolding(s) in Company
23rd Oct 20241:25 pmRNSHolding(s) in Company
9th Oct 20244:34 pmRNSBlock listing Interim Review
2nd Oct 20244:16 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSInterim results for the period ended 30 June 2024
18th Sep 20247:00 amRNSNew Premium Funding & TVR
30th Jul 20245:09 pmRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
10th Jul 20245:19 pmRNSHolding(s) in Company
10th Jul 20245:16 pmRNSHolding(s) in Company
26th Jun 20241:51 pmRNSResult of AGM
24th Jun 20247:59 amRNSDirector Appointment
5th Jun 20244:31 pmRNSHolding(s) in Company
5th Jun 20244:29 pmRNSHolding(s) in Company
3rd Jun 20243:45 pmRNSBoard Changes & Appointment of CFO
31st May 20247:00 amRNSFinal Results
29th May 20249:27 amRNSNOTIFICATION OF MAJOR HOLDINGS
13th May 20247:00 amRNSDirectorate Change
10th May 20247:00 amRNSUpdate on US gas and helium investment
9th May 20244:49 pmRNSHolding(s) in Company
23rd Apr 20247:00 amRNSOnshore US Gas Investment, New Funding &TVR
18th Apr 20241:42 pmRNSGeoenergo Administration: RJOA Status & Claim
2nd Apr 20242:41 pmRNSConfirmation of Geoenergo d.o.o. administration
4th Mar 20243:25 pmRNSResults of General Meeting
28th Feb 202411:27 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSUpdate on ECT claim
5th Feb 20247:00 amRNSNotice of Record Date, GM & posting of Circular
1st Feb 202411:57 amRNSBlock listing Interim Review
19th Jan 20243:32 pmRNSUpdate on JV Partner’s Insolvency Proceedings
16th Jan 202410:34 amRNSHolding(s) in Company - Correction
15th Jan 20241:09 pmRNSHolding(s) in Company
15th Jan 20247:00 amRNSAscent Prevents JV Partner’s Immediate Insolvency
8th Jan 20243:13 pmRNSJV Partner Initiates Insolvency Proceedings
21st Dec 20237:00 amRNSUpgrade in Estimate of Revenue Recognition
1st Dec 20237:00 amRNSECT Claim Distribution Update
21st Nov 20231:30 pmRNSDirector Appointment
15th Nov 20235:41 pmRNSResult of GM
13th Nov 20232:40 pmRNSHolding(s) in Company
27th Oct 202312:22 pmRNSNotice of GM and ECT Claim Shareholder Discussion
26th Oct 20234:50 pmRNSHolding(s) in Company
25th Oct 202312:10 pmRNSSuccessful Revenue Recognition Arbitration
25th Oct 20237:00 amRNSDirectorate Change
19th Oct 20233:19 pmRNSHolding(s) in Company
17th Oct 202310:14 amRNSHolding(s) in Company
11th Oct 202310:35 amRNSCompletion of Strategic Investment & TVR
3rd Oct 20237:00 amRNSCornerstone investor & Collaboration Agreement
28th Sep 20237:00 amRNSInterim Results
22nd Sep 202312:07 pmRNSSlovenia ECT Claim: ATE insurance contracted
21st Sep 20233:35 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.